Navigating your molecular lab’s test selection and development over the next two years
Read more
Blog
On June 20, 2024 | By The Velsera Clinical and Compliance Team
News
On June 3, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show
Read more
Blog
On May 21, 2024 | By Bojana Smiljanic
Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline
Read more
Blog
On May 14, 2024 | By The Velsera Clinical and Compliance Team
Four Years, Five Stages: the FDA’s Final Rule on LDTs
Read more
News
On April 4, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research
Read more
News
On March 5, 2024 | By The Velsera Clinical and Compliance Team
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
Read more
News
On November 15, 2023 | By The Velsera Clinical and Compliance Team
Faster, smarter clinical interpretation workflows unveiled on CGW platform
Read more
News
On November 3, 2023 | By The Velsera Clinical and Compliance Team
Velsera & Solaris Health expand access to genetic testing for urology patients
Read more
News
On November 2, 2023 | By The Velsera Clinical and Compliance Team
Velsera & NVIDIA make Parabricks available on Seven Bridges platform
Read more
News
On October 4, 2023 | By The Velsera Clinical and Compliance Team
2023 BioTechX Europe
Read more
News
On June 27, 2023 | By The Velsera Clinical and Compliance Team
Velsera adds two new board members
Read more
News
On May 17, 2023 | By The Velsera Clinical and Compliance Team
2023 Bio-IT World Conference
Read more